Back to Search
Start Over
Comparison of a home-based (multi) systemic intervention to promoting Medication AdheRence and Self-management among kidney transplant recipients with care-as-usual: the MARS randomized controlled trial protocol
- Source :
- BMC Nephrology, BMC Nephrology, 21(1):374. BioMed Central Ltd., BMC Nephrology, Vol 21, Iss 1, Pp 1-13 (2020)
- Publication Year :
- 2020
-
Abstract
- Background After kidney transplantation non-adherence and inadequate self-management undermine clinical outcomes and quality of life. Both have been demonstrated to be substantial in all age groups. However, interventions promoting adherence and self-management among kidney transplant recipients that have proven to be effective are scarce. In this study we aim to develop and test an intervention to optimize adherence and self-management. In this article we describe the background and design of the trial entitled ‘promoting Medication AdheRence and Self-management among kidney transplant recipients’ (MARS-trial)’. Methods/design This is a single-center, parallel arm randomized controlled trial. Nonadherent kidney transplant recipients aged 12 years or older are eligible for inclusion. Patients will be randomly assigned to either the experimental or a control group. The control group will receive care-as-usual. The experimental group will receive care-as-usual plus the MARS-intervention. The MARS-intervention is an outreaching intervention, based on the principles of (multi) systemic therapy which means involving the social network. A standardized intervention protocol is used for consistency but we will tailor the behavior change techniques used to the specific needs and determinants of each patient. The primary outcome of medication adherence will be measured using electronic monitoring. Secondary outcome measures regarding medication adherence and self-management are also assessed. Data is collected at baseline (T0), after a run-in period (T1), at six months post-baseline/end of treatment (T2) and after a six month follow-up period (T3). Discussion We combined elements of (multi) systemic therapy and evidence-based behavior change techniques to create an outreaching and highly individualized intervention. In this trial we will investigate the impact on medication adherence and self-management after kidney transplantation. Trial registration Netherlands Trial Register,trial number NTR7462. Registered 7th September 2018, https://www.trialregister.nl/trial/7264
- Subjects :
- Nephrology
Graft Rejection
medicine.medical_specialty
030232 urology & nephrology
Psychological intervention
Intervention
030204 cardiovascular system & hematology
Patient Health Questionnaire
lcsh:RC870-923
law.invention
Medication Adherence
Social Networking
03 medical and health sciences
Study Protocol
0302 clinical medicine
Randomized controlled trial
Quality of life
Behavior change
law
Internal medicine
medicine
Humans
Kidney transplantation
Randomized Controlled Trials as Topic
Self-management
business.industry
Self-Management
Social Support
Behavior change methods
lcsh:Diseases of the genitourinary system. Urology
medicine.disease
Kidney Transplantation
Transplant Recipients
Adherence
Physical therapy
Quality of Life
Kidney Failure, Chronic
business
Immunosuppressive Agents
Subjects
Details
- Language :
- English
- ISSN :
- 14712369
- Volume :
- 21
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- BMC Nephrology
- Accession number :
- edsair.doi.dedup.....57fcc03505f2a18340de7d2926478935